This review found that plant sterols and stanols and policosanol reduce low-density lipoprotein cholesterol, and they are well tolerated with only mild side-effects. The authors concluded that policosanol is more effective, but this conclusion came from indirectly comparing the results from different studies. Head-to-head comparisons would be needed to confirm this assertion.
Assessment of study quality
The quality of the studies was assessed on a number of aspects: applicability to the general population, bias and confounding, description of treatment, outcomes and follow-up, and statistical quality and interpretation. Scores of 0 to 100% were awarded. The quality of the studies was scored by the consensus of three reviewers.
Data extraction
The data were extracted by the consensus of three reviewers.
For each group in each study, the percentage change in LDL level was calculated from the baseline mean or median values to the end of study mean or median values. Missing P-values were calculated using an unpaired t-test from posttreatment means and standard deviations. In dose comparison trials, lipid reduction levels from each treatment group were combined. In dose escalation studies, the duration of treatment was considered to be total treatment time, and the final dosage and associated LDL level change were used in the analysis.
Methods of synthesis
How were the studies combined? The mean percentage changes in LDL and other lipid levels were pooled separately for plant stanols or sterols, and for policosanol. The percentage difference was weighted by the number of participants and baseline and/or end of study variability. The Fisher method of combining P-values from individual studies was used to calculate a cumulative Pvalue. An unpaired t-test was used to compare net changes (treatment minus placebo) and baseline lipid parameters of plant sterol and stanol studies with those of policosanol studies.
For pooling data on withdrawals from treatment, pooled relative risks and 95% confidence intervals were calculated using the Mantel-Haenszel method. Where there were no events in a group, 0.5 was added to the tables to facilitate calculations.
How were differences between studies investigated?
Statistical heterogeneity was investigated using the chi-squared test.
Results of the review
Fifty-two trials were included: 23 on plant stanols or sterols (17 parallel trials, 1,204 participants; 6 crossover trials, 229 participants) and 29 on policosanol (2,934 participants).
The authors stated that all studies had comparatively high quality scores, between 69 and 92%.
Plant sterols or stanols.
The weighted mean change in LDL levels were greater with treatment than placebo: -11% with plant sterol or stanols versus -2.3% with placebo. Fisher's combined P-value was less than 0.0001. Compared with placebo, treatment significantly reduced total cholesterol and the LDL:HDL ratio, but there was no effect on triglycerides.
Policosanol.
The weighted mean change in LDL was greater with policosanol than with placebo: -23.7% with policosanol versus -0.1% with placebo. Fisher's combined P-value was less than 0.0001. Compared with placebo, treatment significantly reduced total cholesterol and the LDL:HDL ratio, significantly increased HDL, and caused some decrease in triglycerides.
Comparison between plant sterols or stanols and policosanol.
The net reductions in lipid levels were significantly greater with policosanol than with plant sterols or stanols: the differences observed were -14% in LDL, -9.1% in total cholesterol, -22.1% in LDL:HDL ratio and -10.9% in
